PHIO PHARMACEUTICALS CORP. Proceeds from Warrant Exercises
PHIO PHARMACEUTICALS CORP. (PHIO) reported Proceeds from Warrant Exercises of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromWarrantExercises · last filed 2026-08-06
- PHIO PHARMACEUTICALS CORP. proceeds from warrant exercises for the quarter ending 2026-06-30 was $0.00.
- PHIO PHARMACEUTICALS CORP. proceeds from warrant exercises for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- PHIO PHARMACEUTICALS CORP. proceeds from warrant exercises for the quarter ending 2025-12-31 was $2.83M, a 109.07% increase year-over-year.
- PHIO PHARMACEUTICALS CORP. proceeds from warrant exercises for the quarter ending 2025-09-30 was $200.00K, a 92.44% decline year-over-year.
- PHIO PHARMACEUTICALS CORP. proceeds from warrant exercises for fiscal 2025 was $5.75M, a 43.80% increase from fiscal 2024.
- PHIO PHARMACEUTICALS CORP. proceeds from warrant exercises for fiscal 2024 was $4.00M.
- PHIO PHARMACEUTICALS CORP. proceeds from warrant exercises for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- PHIO PHARMACEUTICALS CORP. proceeds from warrant exercises for fiscal 2021 was $2.15M, a 44.35% decline from fiscal 2020.
| Period end | Proceeds from Warrant Exercises 3 month | Proceeds from Warrant Exercises 3 month as first filed | Proceeds from Warrant Exercises 6 month | Proceeds from Warrant Exercises 9 month | Proceeds from Warrant Exercises 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | $2.83M derived: sum of 3 quarters · filed 2026-08-06 | $3.04M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | $2.83M derived: sum of 2 quarters · filed 2026-05-07 | $3.04M derived: sum of 3 quarters · filed 2026-05-07 | -$738.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $2.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $3.04M derived: sum of 2 quarters · filed 2026-03-05 | -$738.00K derived: sum of 3 quarters · filed 2026-08-06 | $5.75M 10-K · filed 2026-03-05 | |
| 2025-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$3.57M derived: sum of 2 quarters · filed 2026-08-06 | $2.92M 10-Q · filed 2025-11-13 | $4.28M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | -$3.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.72M 10-Q · filed 2026-08-06 | $4.08M derived: sum of 3 quarters · filed 2026-08-06 | $6.72M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $6.49M 10-Q · filed 2026-05-07 | $2.68M 10-Q · filed 2025-05-15 | $7.85M derived: sum of 2 quarters · filed 2026-05-07 | $10.49M derived: sum of 3 quarters · filed 2026-05-07 | $10.49M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $4.00M derived: sum of 2 quarters · filed 2026-03-05 | $4.00M derived: sum of 3 quarters · filed 2026-03-05 | $4.00M 10-K · filed 2026-03-05 | |
| 2024-09-30 | $2.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $2.65M derived: sum of 2 quarters · filed 2025-11-13 | $2.65M 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $0.00 10-Q · filed 2025-08-14 | |||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-15 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $0.00 derived: sum of 2 quarters · filed 2023-03-22 | $0.00 derived: sum of 3 quarters · filed 2023-03-22 | $0.00 10-K · filed 2023-03-22 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | $0.00 derived: sum of 4 quarters · filed 2023-03-22 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $0.00 10-Q · filed 2022-08-11 | $0.00 derived: sum of 3 quarters · filed 2023-03-22 | $0.00 derived: sum of 4 quarters · filed 2023-03-22 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-12 | $0.00 derived: sum of 2 quarters · filed 2023-03-22 | $0.00 derived: sum of 3 quarters · filed 2023-03-22 | $0.00 derived: sum of 4 quarters · filed 2023-03-22 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $0.00 derived: sum of 2 quarters · filed 2023-03-22 | $0.00 derived: sum of 3 quarters · filed 2023-03-22 | $2.15M 10-K · filed 2023-03-22 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $2.15M 10-Q · filed 2022-11-10 | $2.15M derived: sum of 4 quarters · filed 2022-05-12 | |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-12 | $2.15M 10-Q · filed 2022-08-11 | $2.15M derived: sum of 3 quarters · filed 2022-05-12 | $2.15M derived: sum of 4 quarters · filed 2022-05-12 | |
| 2021-03-31 | $2.15M 10-Q · filed 2022-05-12 | $2.15M derived: sum of 2 quarters · filed 2022-05-12 | $2.15M derived: sum of 3 quarters · filed 2022-05-12 | $6.01M derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $0.00 derived: sum of 2 quarters · filed 2022-03-22 | $3.86M derived: sum of 3 quarters · filed 2022-03-22 | $3.86M 10-K · filed 2022-03-22 | |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-10 | $3.86M derived: sum of 2 quarters · filed 2021-11-10 | $3.86M 10-Q · filed 2021-11-10 | $3.88M derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $3.86M 10-Q · filed 2021-08-12 | $3.86M 10-Q · filed 2021-08-12 | $3.88M derived: sum of 3 quarters · filed 2021-08-12 | $3.88M derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | $1.00K 10-Q · filed 2021-05-13 | $13.00K derived: sum of 2 quarters · filed 2021-05-13 | $13.00K derived: sum of 3 quarters · filed 2021-05-13 | $30.00K derived: sum of 4 quarters · filed 2021-05-13 | |
| 2019-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $12.00K derived: sum of 2 quarters · filed 2021-03-25 | $29.00K derived: sum of 3 quarters · filed 2021-03-25 | $72.00K 10-K · filed 2021-03-25 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $17.00K derived: sum of 2 quarters · filed 2020-11-10 | $60.00K 10-Q · filed 2020-11-10 | $165.00K derived: sum of 4 quarters · filed 2020-11-10 | |
| 2019-06-30 | $17.00K 10-Q · filed 2020-08-12 | $60.00K 10-Q · filed 2020-08-12 | $165.00K derived: sum of 3 quarters · filed 2020-08-12 | $165.00K derived: sum of 4 quarters · filed 2020-08-12 | |
| 2019-03-31 | $43.00K 10-Q · filed 2020-05-12 | $148.00K derived: sum of 2 quarters · filed 2020-05-12 | $148.00K derived: sum of 3 quarters · filed 2020-05-12 | $148.00K derived: sum of 4 quarters · filed 2020-05-12 | |
| 2018-12-31 | $105.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $105.00K derived: sum of 2 quarters · filed 2020-03-26 | $105.00K derived: sum of 3 quarters · filed 2020-03-26 | $105.00K 10-K · filed 2020-03-26 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $0.00 10-Q · filed 2019-08-12 | |||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-14 | ||||
| 2017-12-31 | $0.00 10-K · filed 2019-03-27 | ||||
| 2015-12-31 | $182.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $182.00K derived: sum of 2 quarters · filed 2017-03-30 | $198.00K derived: sum of 3 quarters · filed 2017-03-30 | $198.00K 10-K · filed 2017-03-30 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $16.00K derived: sum of 2 quarters · filed 2016-11-10 | $16.00K 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | $16.00K 10-Q · filed 2015-08-12 | $16.00K 10-Q · filed 2016-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |